Ken Griffin Esperion Therapeutics, Inc. Transaction History

Citadel Advisors LLC

  • $618 Billion
  • Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 85,600 shares of ESPR stock, worth $248,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,600
Previous 2,329,133 96.32%
Holding current value
$248,240
Previous $2.28 Million 90.1%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.98 - $2.84 $782,793 - $2.27 Million
-798,769 Reduced 34.29%
1,530,364 $4.06 Million
Q2 2025

Aug 14, 2025
BUY
$0.73 - $1.41 $173,760 - $335,619
238,028 Added 11.38%
2,329,133 $2.28 Million
Q1 2025

May 15, 2025
BUY
$1.44 - $2.34 $484,521 - $787,346
336,473 Added 19.18%
2,091,105 $3.01 Million
Q4 2024

Feb 14, 2025
BUY
$1.61 - $3.83 $2.61 Million - $6.21 Million
1,621,016 Added 1213.19%
1,754,632 $3.86 Million
Q3 2024

Nov 14, 2024
SELL
$1.61 - $2.73 $2.23 Million - $3.79 Million
-1,388,161 Reduced 91.22%
133,616 $220,000
Q2 2024

Aug 14, 2024
SELL
$1.84 - $3.24 $3.39 Million - $5.96 Million
-1,840,433 Reduced 54.74%
1,521,777 $3.38 Million
Q1 2024

May 15, 2024
BUY
$2.02 - $3.02 $5.86 Million - $8.76 Million
2,899,928 Added 627.31%
3,362,210 $9.01 Million
Q4 2023

Feb 14, 2024
SELL
$0.73 - $3.08 $138,164 - $582,939
-189,266 Reduced 29.05%
462,282 $1.38 Million
Q3 2023

Nov 14, 2023
SELL
$0.96 - $1.79 $53,017 - $98,856
-55,227 Reduced 7.81%
651,548 $638,000
Q2 2023

Aug 14, 2023
SELL
$1.2 - $1.76 $37,687 - $55,274
-31,406 Reduced 4.25%
706,775 $982,000
Q1 2023

May 15, 2023
SELL
$1.46 - $7.3 $1.19 Million - $5.93 Million
-811,815 Reduced 52.38%
738,181 $1.17 Million
Q4 2022

Feb 14, 2023
BUY
$5.09 - $8.5 $5.27 Million - $8.8 Million
1,035,258 Added 201.12%
1,549,996 $9.66 Million
Q3 2022

Nov 14, 2022
BUY
$5.45 - $8.13 $2.25 Million - $3.36 Million
413,144 Added 406.66%
514,738 $3.45 Million
Q2 2022

Aug 15, 2022
BUY
$4.77 - $6.67 $297,056 - $415,380
62,276 Added 158.39%
101,594 $646,000
Q1 2022

May 16, 2022
SELL
$3.34 - $5.56 $642,946 - $1.07 Million
-192,499 Reduced 83.04%
39,318 $182,000
Q4 2021

Feb 14, 2022
BUY
$4.81 - $11.92 $614,958 - $1.52 Million
127,850 Added 122.97%
231,817 $1.16 Million
Q3 2021

Nov 15, 2021
BUY
$11.34 - $21.37 $464,418 - $875,186
40,954 Added 64.99%
103,967 $1.25 Million
Q2 2021

Aug 16, 2021
BUY
$19.4 - $28.71 $184,280 - $272,716
9,499 Added 17.75%
63,013 $1.33 Million
Q1 2021

May 17, 2021
SELL
$25.12 - $36.89 $3.84 Million - $5.64 Million
-152,860 Reduced 74.07%
53,514 $1.5 Million
Q4 2020

Feb 16, 2021
BUY
$24.2 - $35.76 $4.12 Million - $6.09 Million
170,207 Added 470.61%
206,374 $5.37 Million
Q3 2020

Nov 16, 2020
SELL
$31.18 - $52.71 $1.4 Million - $2.37 Million
-44,871 Reduced 55.37%
36,167 $1.34 Million
Q2 2020

Aug 14, 2020
SELL
$30.04 - $51.31 $3.28 Million - $5.59 Million
-109,029 Reduced 57.36%
81,038 $4.16 Million
Q1 2020

May 15, 2020
BUY
$27.44 - $73.84 $692,640 - $1.86 Million
25,242 Added 15.31%
190,067 $5.99 Million
Q4 2019

Feb 14, 2020
SELL
$35.4 - $59.82 $4.85 Million - $8.2 Million
-137,039 Reduced 45.4%
164,825 $9.83 Million
Q3 2019

Nov 14, 2019
BUY
$34.47 - $47.53 $3.21 Million - $4.43 Million
93,101 Added 44.6%
301,864 $11.1 Million
Q2 2019

Aug 14, 2019
BUY
$40.1 - $52.33 $4.36 Million - $5.7 Million
108,847 Added 108.94%
208,763 $9.71 Million
Q1 2019

May 15, 2019
BUY
$40.11 - $53.57 $1.48 Million - $1.98 Million
36,971 Added 58.74%
99,916 $0
Q4 2018

Feb 14, 2019
BUY
$36.99 - $59.11 $56,039 - $89,551
1,515 Added 2.47%
62,945 $2.9 Million
Q3 2018

Nov 13, 2018
BUY
$40.74 - $51.41 $1.81 Million - $2.29 Million
44,487 Added 262.57%
61,430 $0
Q2 2018

Aug 10, 2018
SELL
$36.2 - $76.4 $16 Million - $33.7 Million
-441,084 Reduced 96.3%
16,943 $0
Q1 2018

May 11, 2018
BUY
$65.94 - $80.76 $18.7 Million - $23 Million
284,335 Added 163.7%
458,027 $33.1 Million
Q4 2017

Feb 09, 2018
BUY
$43.47 - $67.43 $5.01 Million - $7.78 Million
115,360 Added 197.76%
173,692 $11.4 Million
Q3 2017

Nov 09, 2017
BUY
$43.8 - $52.77 $2.55 Million - $3.08 Million
58,332
58,332 $2.92 Million

Others Institutions Holding ESPR

# of Institutions
214
Shares Held
114M
Call Options Held
643K
Put Options Held
769K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $193M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email